March 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Immutep Limited (“Immutep” or “the Company”) (NASDAQ: IMMP). Investors who purchased Immutep securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Immutep has violated federal… read more
March 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Immutep Limited (“Immutep” or “the Company”) (NASDAQ: IMMP). Investors who purchased Immutep securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Immutep has violated federal… read more
March 13, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zillow Group, Inc. (“SZillow” or “the Company”) (NASDAQ: ZG). Investors who purchased SZillow securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether SZillow has violated… read more
March 13, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Jefferies Financial Group, Inc. (“Jefferies” or “the Company”) (NYSE: JEF). Investors who purchased Jefferies securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Jefferies has… read more
March 13, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Via Transportation, Inc. (“Via” or “the Company”) (NYSE: VIA). Investors who purchased Via securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Via has violated… read more
March 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of BlackRock, Inc. (“BlackRock” or “the Company”) (NYSE: BLK). Investors who purchased BlackRock securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether BlackRock has violated federal… read more
March 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AeroVironment, Inc. (“AeroVironment” or “the Company”) (NASDAQ: AVAV). Investors who purchased AeroVironment securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether AeroVironment has violated federal… read more
March 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Snap, Inc. (“Snap” or “the Company”) (NYSE: SNAP). Investors who purchased Snap securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Snap has violated federal… read more
March 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CVRx, Inc. (“CVRx” or “the Company”) (NASDAQ: CVRX). Investors who purchased CVRx securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether CVRx has violated federal… read more
March 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Encompass Health Corporation (“Encompass” or “the Company”) (NYSE: EHC). Investors who purchased Encompass securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Encompass has violated… read more
March 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PROCEPT BioRobotics Corporation (“PROCEPT” or “the Company”) (NASDAQ: PRCT). Investors who purchased PROCEPT securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether PROCEPT has violated… read more
March 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Edison International (“Edison” or “the Company”) (NYSE: EIX). Investors who purchased Edison securities prior to February 25, 2021, and continue to hold to the present, are encouraged to obtain additional information… read more
March 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Varonis Systems, Inc. (“Varonis” or “the Company”) (NASDAQ: VRNS). Investors who purchased Varonis securities prior to February 4, 2025, and continue to hold to the present, are encouraged to obtain additional… read more
March 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ardent Health, Inc. (“Ardent” or “the Company”) (NYSE: ARDT). Investors who purchased Ardent securities prior to July 18, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
March 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sprouts Farmers Market, Inc. (“Sprouts” or “the Company”) (NASDAQ: SFM). Investors who purchased Sprouts securities prior to June 4, 2025, and continue to hold to the present, are encouraged to obtain… read more
March 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Centene Corporation (“Centene” or “the Company”) (NYSE: CNC). Investors who purchased Centene securities prior to December 12, 2024, and continue to hold to the present, are encouraged to obtain additional information… read more
March 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. (“iRhythm” or “the Company”) (NASDAQ: IRTC). Investors who purchased iRhythm securities prior to January 11, 2022, and continue to hold to the present, are encouraged to obtain additional… read more
March 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lockheed Martin Corporation (“Lockheed” or “the Company”) (NYSE: LMT). Investors who purchased Lockheed securities prior to January 23, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
March 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DexCom, Inc. (“DexCom” or “the Company”) (NASDAQ: DXCM). Investors who purchased DexCom securities prior to January 8, 2024, and continue to hold to the present, are encouraged to obtain additional information… read more
March 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Future FinTech Group Inc. (“Future FinTech” or “the Company”) (NASDAQ: FTFT). Investors who purchased Future FinTech securities prior to March 10, 2020, and continue to hold to the present, are encouraged… read more
March 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Distribution Solutions Group, Inc. (“DSG” or “the Company”) (NASDAQ: DSGR). Investors who purchased DSG securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether DSG has… read more
March 9, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sempra (“Sempra” or “the Company”) (NYSE: SRE). Investors who purchased Sempra securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Sempra has violated federal securities… read more
March 6, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hims & Hers Health, Inc. (“Hims & Hers” or “the Company”) (NYSE: HIMS). Investors who purchased Hims & Hers securities prior to April 1, 2025, and continue to hold to the… read more
March 4, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Barclays PLC (“Barclays” or “the Company”) (NYSE: BCS). Investors who purchased Barclays securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Barclays has violated federal… read more
March 4, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Banco Santander, S.A. (“Santander” or “the Company”) (NYSE: SAN). Investors who purchased Santander securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Santander has violated… read more
March 4, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SLM Corporation a/k/a Sallie Mae (“SLM” or “the Company”) (NASDAQ: SLM). Investors who purchased SLM securities prior to July 25, 2025, and continue to hold to the present, are encouraged to… read more
March 4, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elevance Health, Inc. (“Elevance” or “the Company”) (NYSE: ELV). Investors who purchased Elevance securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Elevance has violated… read more
March 4, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elauwit Connection, Inc. (“Elauwit” or “the Company”) (NASDAQ: ELWT). Investors who purchased Elauwit securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Elauwit has violated… read more
March 2, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Duolingo, Inc. (“Duolingo” or “the Company”) (NASDAQ: DUOL). Investors who purchased Duolingo securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Duolingo has violated federal… read more
March 2, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rambus Inc. (“Rambus” or “the Company”) (NASDAQ: RMBS). Investors who purchased Rambus securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Rambus has violated federal… read more